AzTrials
AzTrials

Consciousness DisordersNCT02714491

Effects of Auditory Stimulation During Verticalization With Erigo in Patients With Disorder of Consciousness

A study testing Erigo + Music, Erigo + Metronome and Erigo + Silence in people with Consciousness Disorders, run by Ospedale Generale Di Zona Moriggia-Pelascini at 1 site in Italy.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Aim of the study is to define if the auditory stimulation during stepping verticalization sessions with "Erigo" is able to modify the cerebral electric activity or improve consciousness in patients affected by vegetative state or minimally conscious state. Read more about this study

Who is it for?
Ages 18 to 75 years
Conditions the study is for
Consciousness Disorders
What is being tested?
Erigo + Music, Erigo + Metronome and Erigo + Silence
Could I receive a placebo?
No, everyone receives an active treatment
How many people
15 participants
Where
1 siteItaly
Study dates
Jun 2015to Jun 2017
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 75 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Vegetative State or Minimally Conscious State diagnosis
  • >3 months from acute brain injury

Who cannot join

  • No clinical stability
  • Sepsis
  • Orthopaedic contraindications for verticalization
  • Deep Vein Thrombosis
  • weight >130 Kg
  • height >210 cm

Trial locations and contacts

1 site in 1 country.

Giuseppe Frazzitta, MD contact

+39034492111

frazzittag62@gmail.com

Italy1 site, 1 recruiting
  • Ospedale Generale di Zona Moriggia Pelascini

    Gravedona Ed Uniti, CO, 22015

    Giuseppe Frazzitta, MD, +39034492111, frazzittag62@gmail.com

    Recruiting

Other trials in Italy

About this study

Aim of the study is to define if the auditory stimulation during stepping verticalization sessions with "Erigo" is able to modify the cerebral electric activity or improve consciousness in patients affected by vegetative state or minimally conscious state.

Being tested
Erigo + Music, Erigo + Metronome, Erigo + Silence
Medical subject headings
Consciousness Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Erigo + MusicOther

    The patients receive daily conventional physiotherapy + fifteen 30-minutes stepping verticalization sessions with "Erigo" (3/week for 5 consecutive weeks) and musical stimulation.

  • Erigo + MetronomeOther

    The patients receive daily conventional physiotherapy + fifteen 30-minutes stepping verticalization sessions with "Erigo" (3/week for 5 consecutive weeks) and metronome stimulation.

  • Erigo + SilenceOther

    The patients receive daily conventional physiotherapy + fifteen 30-minutes stepping verticalization sessions with "Erigo" (3/week for 5 consecutive weeks), without auditory stimulation.

Study groups in NCT02714491
Study groupRoleWhat they receive
MusicActive comparatorErigo + Music: During each stepping verticalization session the patient receives auditory stimulation (earphones) with previously preferred music
Receives: Other: Erigo + Music
MetronomeActive comparatorErigo + Metronome: During each stepping verticalization session the patient receives auditory stimulation (earphones) with a metronome (rhythmic with the stepping movement)
Receives: Other: Erigo + Metronome
SilenceActive comparatorErigo + Silence: During each stepping verticalization session the patient does note receive any auditory stimulation.
Receives: Other: Erigo + Silence

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. change in Coma Recovery Scale revised score

    Measured: 0 and 35 days

Secondary outcomes (4)
  1. change in Levels of Cognitive Functioning score

    Measured: 0 and 35 days

  2. change in Disability Rating Scale score

    Measured: 0 and 35 days

  3. change in quantitative EEG parameters

    Measured: 0 and 35 days

  4. change in Glasgow Coma Scale score

    Measured: 0 and 35 days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted21 Mar 2016 (estimated)
  2. Study startJun 2015
  3. Primary completionJun 2017 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
15 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02714491
Sponsor's protocol ID
Erigo.stim
Status last verified
Sep 2016
First submitted
10 Mar 2016
Last updated
30 Sep 2016
Results posted
No

Questions about this trial

What is this clinical trial studying?

A study testing Erigo + Music, Erigo + Metronome and Erigo + Silence in people with Consciousness Disorders, run by Ospedale Generale Di Zona Moriggia-Pelascini at 1 site in Italy.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 30 Sep 2016. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Giuseppe Frazzitta, MD (+39034492111, frazzittag62@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

change in Coma Recovery Scale revised score (time frame: 0 and 35 days). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Sep 2016.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in